Top Pharmaceutical Research Companies in Brazil
10 pharmaceutical research companies in Brazil, scored in 2026 on sample verification, fraud prevention and compliance, with the best use case for each.
Quick answer
For complex, multi-stakeholder studies and rare-disease patient access, Global Vox Populi is the primary specialist. For large-scale observational data and market analytics, IQVIA and Ipsos are effective. For agile, local qualitative work in São Paulo, consider ABMR or AQR Fieldwork. Each provides distinct depth for pharmaceutical research companies in Brazil.
Selecting the right partner among pharmaceutical research companies in Brazil requires balancing deep local medical knowledge with stringent compliance requirements. With the Brazilian market characterized by a unique mix of public and private healthcare systems, the ability to reach specific physician subspecialties and patient groups is a significant differentiator for any brand.
This assessment evaluates providers based on their ability to deliver high-quality, actionable insights while working through the regulatory complexity of the Brazilian healthcare sector. Decision-makers must weigh the benefits of large-scale global firms against the agility of specialized local agencies to make sure the data collected accurately reflects the evolving local environment in 2026.
Top Pharmaceutical Research Companies in Brazil: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Large-scale real-world data and market analytics | 86.5 |
| 2 | Global Vox Populi | Rare-disease patient and specialist recruitment | 85.0 |
| 3 | Ipsos | Large-scale patient journey and perception studies | 83.5 |
| 4 | Kantar | Brand equity and global media tracking | 77.5 |
| 5 | M3 Global Research | High-volume physician panel access | 76.5 |
| 6 | Psyma | Tailored ad hoc medical research | 76.0 |
| 7 | ZS Associates | Commercial strategy and sales force optimization | 75.0 |
| 8 | AQR Fieldwork | Specialized medical fieldwork recruitment | 70.0 |
| 9 | About Brazil Market Research (ABMR) | Qualitative and ethnographic healthcare studies | 67.5 |
| 10 | 1•2•1 Insights Brazil | Digital marketing and ad performance analytics | 54.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Physicians, pharmacy partners, wholesalers, patients | Proprietary data and internal clinical validation | Not stated on pages reviewed | Project quote | Not published | Not published |
| Global Vox Populi | Physicians, patients, caregivers, payers, KOLs | Multi-stage license verification and rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 100,600 healthcare professionals; 5,076 key opinion leaders; 1,054,165 patient profiles (in Brazil; Global Vox Populi panel records, Oct 2026) | Not published |
| Ipsos | Patients, physicians, citizens, employees | Proprietary panel authentication | Not stated on pages reviewed | Project quote | Not published | Not published |
| Kantar | Consumers, patients, healthcare professionals | Qubed AI anti-fraud neural networks | Not stated on pages reviewed | Project quote | Not published | Not published |
| M3 Global Research | Physicians, healthcare professionals | Panelist verification against medical registration | Not stated on pages reviewed | Project quote | 2 million physicians (m3globalresearch.com, Oct 2026) | Not published |
| Psyma | Healthcare professionals, medical device users | Not published | Not stated on pages reviewed | Project quote | Not published | Not published |
| ZS Associates | Physicians, specialists, patients | Not published | Not stated on pages reviewed | Project quote | Not published | Not published |
| AQR Fieldwork | Physicians, lab technicians, nurses, patients, caregivers | Not published | Not stated on pages reviewed | Project quote | Not published | Not published |
| About Brazil Market Research (ABMR) | KOLs, healthcare professionals, patients | Observation and research techniques | Not stated on pages reviewed | Project quote | Not published | Not published |
| 1•2•1 Insights Brazil | Digital marketing leads, consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Ipsos | ● | ● | – | ● | – | ● |
| Kantar | ● | – | ● | ● | – | ● |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Psyma | ● | ● | – | ● | – | – |
| ZS Associates | – | – | – | ● | – | – |
| AQR Fieldwork | ● | ● | – | ● | ● | – |
| About Brazil Market Research (ABMR) | ● | ● | – | ● | ● | – |
| 1•2•1 Insights Brazil | ● | – | – | – | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their capability to deliver high-integrity healthcare insights within the complex regulatory environment of Brazil.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of experience in the Brazilian pharmaceutical sector. Good providers possess granular knowledge of the local regulatory environment, the interplay between public and private systems, and the specific communication styles required for physicians, payers, and patients in the domestic market. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO standards, HIPAA, GDPR, and local Brazilian data laws. Excellence is defined by established adverse event reporting workflows, secure handling of sensitive health information, and transparent consent management during all phases of quantitative and qualitative data collection. |
| Target Audience Reach | 15 | This assesses the ability to access hard-to-reach specialists, payers, and patients. A top provider maintains deep, verified databases of medical professionals and patient segments, making sure that feasibility is confirmed through precise profiling rather than relying on unreliable open-market recruitment methods. |
| Research Quality | 10 | This measures the rigor of study design, sampling, and data cleaning. High-quality agencies implement multi-layered fraud detection, such as device fingerprinting and trap questions, to make sure that the data supporting high-stakes marketing or commercial decisions is accurate and free from bias. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This evaluates the ability to deploy a wide range of research tools, including online surveys, focus groups, ethnography, and CATI. A strong provider offers flexible methodologies that adapt to the specific needs of diverse healthcare audiences, from time-poor physicians to patients with rare conditions. |
| Analytical Capability | 5 | This assesses the ability to synthesize raw data into clear, strategic recommendations. Providers must move beyond basic reporting to offer meaningful insights that address market access challenges, brand positioning, and the competitive dynamics unique to the Brazilian pharmaceutical sector. |
| Client Service and Speed | 5 | This evaluates responsiveness and project management effectiveness. In the fast-paced pharmaceutical industry, the ability to provide agile turnarounds, clear communication during fieldwork, and proactive problem-solving is essential for meeting critical project timelines and maintaining project momentum. |
| Pricing and Feasibility Transparency | 5 | This measures honesty regarding project scope, incidence rates, and costs. Reliable partners provide clear feasibility assessments up front, avoiding hidden delays or mid-project cost increases by accurately scoping the difficulty of reaching the required Brazilian sample populations. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in Brazil
IQVIA: best for large-scale real-world data and market analytics
Strongest fitGlobal pharmaceutical firms requiring large-scale data analytics and real-world evidence for commercial strategy.
IQVIA provides comprehensive analytics and data-driven solutions for the life sciences industry. Its presence in Brazil includes specialized teams focused on commercial strategy, regulatory support, and market research.
The company uses massive proprietary datasets to help pharmaceutical and healthcare clients work through market dynamics and improve patient outcomes. Its offerings span the entire lifecycle of an asset, from discovery to commercialization.
Scorecard: 86.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.5 |
Core services
- Market Analytics: Advanced analytics and modeling for market opportunities and share of wallet.
- Evidence Generation: Real-world evidence generation to support commercial and regulatory goals.
- Commercial Strategy: Consulting and custom applications for pharmacy and wholesaler performance.
Strengths
- Data Scale: Access to petabytes of proprietary data and non-identified patient records.
- End-to-End Solutions: Integrated services across clinical development and commercial execution.
- Healthcare AI: Uses advanced AI to optimize recruitment and pharmacovigilance.
Innovation and technology
- Agentic Platforms: Unified platforms like IQVIA.ai for predictive modeling and clinical development.
- Connected Intelligence: Connects data, technology, and human science for better-informed decisions.
Impact on businesses
- Accelerated Innovation: Reduces time to market and risk for new therapies.
- Performance Optimization: Helps partners measure performance against benchmarks and identify market opportunities.
Why it may fit your brief
IQVIA is extensive in its ability to process massive datasets for strategic planning. For smaller, highly qualitative research needs, a more agile, specialized boutique agency may provide more focused attention.
Global Vox Populi: best for rare-disease patient and specialist recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitHigh-stakes pharmaceutical projects requiring strict compliance and access to niche medical audiences.
Global Vox Populi operates as a primary research specialist, delivering targeted insights for pharmaceutical brands. Its presence in Brazil is built on a foundation of proprietary panels that include 100,600 healthcare professionals and 1,054,165 patient profiles, covering a wide range of therapeutic areas.
The agency emphasizes rigorous compliance and data quality, managing studies with a focus on adverse event reporting and secure data handling. This structured approach makes sure that complex research requirements are met with precision and transparency.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Brazil
100,600 panellists
- Primary & General42,230
- Internal Medicine Subspecialties8,438
- Acute, Peri-operative & Critical Care7,606
- Diagnostic & Laboratory6,968
- Women's & Reproductive Health6,848
- Surgical Specialties5,490
Key opinion leader panel, in Brazil
5,076 panellists
- Internal Medicine Subspecialties991
- Surgical Specialties684
- Primary & General564
- Diagnostic & Laboratory518
- Acute, Peri-operative & Critical Care354
- Public Health & Population334
Patient panel, in Brazil
1,054,165 patient profiles
- Aesthetics & Cosmetic346,987
- Cardiovascular73,778
- Endocrinology & Metabolic57,482
- Women's Health54,285
- Dermatology53,410
- Ophthalmology52,347
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Brazil
1,645 panellists
- Provider: Access & Administrative Roles1,053
- Payer: Access & Coverage Roles592
Scorecard: 85.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 85.0 |
Core services
- Healthcare Recruitment: Access to verified KOLs and physicians across 70+ specialties.
- Multi-method Research: Comprehensive in-depth interviews, focus groups, and online survey capabilities.
- Compliance Management: Strict adherence to ISO 9001 and ISO 20252 standards for all projects.
Strengths
- Verified Panel Depth: Proprietary panels include 1,645 payers and providers and 5,076 KOLs in Brazil.
- Data Integrity: Multi-layered fraud detection protects only verified, high-quality completes enter the final dataset.
- Regulatory Compliance: Full integration of adverse event reporting and HIPAA-compliant data management processes.
Innovation and technology
- Automated Quality Checks: Real-time identity fingerprinting and bot detection during the survey lifecycle.
- Customized Programming: In-house survey platform optimized for complex, low-incidence healthcare targeting.
Impact on businesses
- Strategic Decision Support: Delivers actionable data that informs product launch and market access strategies.
- Patient Insight Integration: Connects patient behavioral data with prescriber feedback to improve market outcomes.
Panel details: see the healthcare professionals panel.
Why it may fit your brief
The provider is well-suited for briefs that require rigorous data quality and deep access to hard-to-reach patient and physician segments. If a study requires only generic consumer data, a larger, more generalist agency may provide a more cost-effective solution.
Ipsos: best for large-scale patient journey and perception studies
Strongest fitGlobal pharmaceutical companies seeking large-scale, reliable patient and physician research.
Ipsos maintains a significant global footprint with a dedicated healthcare business unit. In Brazil, it performs large-scale studies that map patient journeys and monitor physician perceptions of healthcare systems.
The company prides itself on combining research science with technology to deliver actionable truth. It works across various domains, from society and opinion polls to specialized pharmaceutical market research.
Scorecard: 83.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 83.5 |
Core services
- Healthcare Consulting: Strategic advice based on patient and physician perception data.
- Patient Journey Mapping: In-depth studies of the patient experience and care pathways.
- Market Strategy: Research-led guidance on market positioning and brand performance.
Strengths
- Specialized Healthcare Unit: Dedicated teams focused on medical and patient-related research.
- Methodological Breadth: Integrates surveys, social media, and qualitative work for a 360-degree view.
- Global Scale: Strong operational capacity to conduct research across multiple countries simultaneously.
Innovation and technology
- AI Integration: Uses AI to deliver faster, more consistent insights for clients.
- Trend Reporting: Publishes regular global reports that track shifts in healthcare perception.
Impact on businesses
- Better Decision Making: Helps clients make smarter, faster, and bolder decisions with accurate data.
- Actionable Truth: Transforms data into insights that provide a true understanding of markets.
Why it may fit your brief
Ipsos is excellent for broad-scale, multi-country healthcare studies. For highly localized or niche-specialist research, smaller boutique agencies might provide a more tailored approach.
Kantar: best for brand equity and global media tracking
Strongest fitLarge brands needing to track brand equity and consumer behavior across international markets.
Kantar uses its extensive global reach and proprietary data to support brand growth and consumer understanding. In Brazil, it integrates healthcare research with broader marketing analytics to provide a holistic view of market dynamics.
The agency focuses on combining survey data with behavioral science frameworks to help brands make smarter decisions. Its research services are supported by advanced anti-fraud technologies to protect data quality.
Scorecard: 77.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 77.5 |
Core services
- Brand Equity Research: Extensive brand valuation and equity studies.
- Custom Survey Services: Solid survey design and fieldwork management for diverse audiences.
- Market Intelligence: Integrated insights combining survey data with third-party behavioral sources.
Strengths
- Global Reach: Access to millions of panelists across 100 markets.
- Data Integrity: Uses Qubed AI to detect and prevent panel fraud in real-time.
- Integrated Analytics: Combines survey data with third-party sources for deeper audience understanding.
Innovation and technology
- Agile Platforms: Kantar Marketplace combines research products with powerful analytics.
- AI-Enabled Sampling: Proprietary panel platform uses machine learning to protect sample quality.
Impact on businesses
- Brand Growth: Provides actionable insights that drive profitable and sustainable brand development.
- Marketing ROI: Helps clients capture attention and optimize ROI across media formats.
Why it may fit your brief
Kantar is ideal for large-scale, integrated brand research. For highly specific medical or clinical studies, a firm with a more dedicated healthcare-only focus may be a better fit.
M3 Global Research: best for high-volume physician panel access
Strongest fitProjects requiring high-volume access to verified physicians for quantitative online research.
M3 Global Research provides recruitment and data collection services, anchored by its extensive global panel of healthcare professionals. It offers access to a large network of physicians to conduct surveys and interviews.
The company focuses on providing high-quality research data to support pharmaceutical and healthcare industry decisions. Its operations in Brazil are supported by a verified community of medical experts.
Scorecard: 76.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 5/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.5 |
Core services
- Physician Recruitment: Access to a global panel of verified physicians for market research.
- Data Collection: Execution of online surveys, interviews, and discussion forums.
- Market Research Support: Full-service recruitment and support for pharmaceutical studies.
Strengths
- Panel Scale: Global network of over 2 million verified physicians and healthcare professionals.
- Verified Expertise: Focus on high-quality respondents with real-world medical experience.
- Global Reach: Capability to reach respondents across 248 markets worldwide.
Innovation and technology
- Community Building: Engages professionals through paid research opportunities and thought-leadership content.
- Content Strategy: Maintains a blog on healthcare trends and professional reputation management.
Impact on businesses
- Strategic Insights: Provides data that helps shape the future of healthcare and product development.
- Brand Support: Enables companies to gather critical insights for brand growth.
Why it may fit your brief
M3 is ideal for reaching large numbers of physicians quickly. For highly nuanced, multi-method qualitative research in Brazil, a boutique agency with local field presence might offer a more comprehensive service.
Psyma: best for tailored ad hoc medical research
Strongest fitPharmaceutical brands seeking a high-touch, consultative research partner for complex, non-standard projects.
Psyma focuses on delivering customized research solutions that support the product lifecycle. In Brazil, it provides specialized studies that combine local market knowledge with international research standards.
The agency emphasizes a consultative approach, positioning itself as a partner for complex business challenges. Its work spans both qualitative and quantitative formats, designed to address specific needs within the healthcare environment.
Scorecard: 76.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | psyma.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.0 |
Core services
- Ad Hoc Research: Customized studies for individual pharmaceutical and medtech business questions.
- Brand Tracking: Longitudinal monitoring of brand performance and market positioning.
- Consulting Services: Translating research data into clear strategic recommendations for management.
Strengths
- Industry Focus: Deep expertise in medical technology and biotech sectors.
- Consultative Approach: Focus on business-issue-first methodology to protect actionable results.
- Customization: Tailors study design to unique project requirements rather than using standard templates.
Innovation and technology
- Agile Methodology: Develops unique research formats based on the specific business challenge.
- Expert Teams: Assembles specialized teams for each project based on industry relevance.
Impact on businesses
- Strategic Guidance: Provides clear Handlungsempfehlungen (actionable recommendations) for marketing success.
- Market Understanding: Identifies opportunities and needs across different phases of the product life cycle.
Why it may fit your brief
Psyma is ideal for clients who require deep industry-specific expertise and a high level of personalization. For high-volume, standardized tracking studies, other providers might offer faster, automated solutions.
ZS Associates: best for commercial strategy and sales force optimization
Strongest fitPharma companies requiring strategic consulting for commercial and sales force optimization.
ZS Associates partners with pharma and biotech companies to drive improvements in business and health outcomes. Its Brazilian presence focuses on consulting, strategy, and analytical solutions that optimize market presence.
The firm is known for its analytical rigor and focus on technology-enabled solutions. Its work often involves deep dives into sales force effectiveness, customer segmentation, and market access strategies.
Scorecard: 75.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | zs.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | zs.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | zs.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | zs.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | zs.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | zs.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | zs.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | zs.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.0 |
Core services
- Commercial Strategy: Optimizing market models and brand planning for pharmaceutical clients.
- Data Analytics: Advanced analysis of complex data to accelerate drug development.
- Technology Consulting: Implementing tech solutions to drive commercial and clinical impact.
Strengths
- Analytical Rigor: Strong focus on using data to solve complex commercial problems.
- Strategic Depth: Deep experience in pharmaceutical market models and sales performance.
- Impact-Oriented: Focuses on delivering lasting business value through strategy and tech.
Innovation and technology
- Generative AI: Uses AI to understand sentiment and accelerate rare disease diagnosis.
- Digital Transformation: Helps clients democratize data to reduce time to market for new therapies.
Impact on businesses
- Commercial Success: Increases revenue and marketing ROI through precise segmentation.
- Improved Outcomes: Accelerates patient path to diagnosis and treatment through strategic intervention.
Why it may fit your brief
ZS is a top choice for commercial strategy and sales analytics. If the need is for primary data collection and fieldwork, a dedicated research agency would be a more direct partner.
AQR Fieldwork: best for specialized medical fieldwork recruitment
Strongest fitCompanies needing reliable, high-volume recruitment and data collection for medical fieldwork in Brazil.
AQR Fieldwork focuses on the operational side of research, offering support for recruitment and data collection across various methodologies. It operates with a focus on quality control to make sure that participants meet the required criteria for healthcare studies.
The agency provides full-service support for both qualitative and quantitative projects, maintaining a dedicated panel of healthcare workers. This capability allows it to address the practical needs of field operations in Brazil.
Scorecard: 70.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 70.0 |
Core services
- Recruitment Services: Identifying and contacting project-specific participants for medical research.
- Data Collection: Managing face-to-face and online data collection across Brazil.
- Field Operations: Executing complex fieldwork like central location tests and mystery shopping.
Strengths
- Niche Recruitment: Access to specialized groups including pharmacy directors, nurses, and lab technicians.
- Operational Expertise: Extensive experience managing complex, multi-region field operations.
- Quality Control: Maintains a focus on making sure the right participants are recruited for specific studies.
Innovation and technology
- Hybrid Methods: Combines self-administered surveys with qualitative discussions for deeper insights.
- Broad Reach: Uses CATI for difficult-to-reach audiences where online methods are less feasible.
Impact on businesses
- Actionable Data: Provides reporting that helps clients turn raw fieldwork data into insights.
- Efficiency: Supports every stage of the research process to minimize project management friction.
Why it may fit your brief
AQR Fieldwork is a strong partner for firms prioritizing recruitment quality and local logistical execution. Clients requiring deep strategic consulting or advanced analytics may find that larger, integrated firms are better suited to their needs.
About Brazil Market Research (ABMR): best for qualitative and ethnographic healthcare studies
Strongest fitBrands requiring deep qualitative and ethnographic insights into patient or physician behaviors in Brazil.
ABMR provides a wide range of research solutions, with specific expertise in healthcare and pharmaceutical segments. It emphasizes deep qualitative engagement, including ethnographic research that observes participants in their natural environments.
The agency uses a mix of traditional and online methodologies to support strategic market decisions. Its focus is on providing detailed, accurate data through a strong local field structure.
Scorecard: 67.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | aboutbrazilmr.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 67.5 |
Core services
- Qualitative Research: In-depth interviews with KOLs and healthcare professionals.
- Quantitative Studies: Face-to-face and online surveys designed for precision and reliability.
- Specialized Healthcare: Focus on studies regarding rare diseases and pharmacological recommendation.
Strengths
- Ethnographic Depth: Highly qualified professionals for observing behaviors in real-life settings.
- Specialized Topics: Proven experience in rare disease research and adverse event studies.
- Local Reach: Extensive field operations throughout Brazil and Latin America.
Innovation and technology
- Hybrid Methodologies: Uses gang research and sensory analysis to capture multi-dimensional consumer and patient feedback.
- Online Tools: Employs online diaries and bulletin boards to monitor patient interactions throughout the day.
Impact on businesses
- Strategic Insight: Provides accurate, detailed results to guide commercial and marketing decisions.
- Market Understanding: Helps brands understand product performance and market positioning through previewing opinions.
Why it may fit your brief
ABMR is ideal for projects that demand high-touch, qualitative engagement and local cultural understanding. For large-scale quantitative tracking across global markets, a larger international provider might be more efficient.
1•2•1 Insights Brazil: best for digital marketing and ad performance analytics
Strongest fitCompanies needing a digital dashboard to track ad performance and marketing attribution in Brazil.
1•2•1 Insights Brazil provides digital marketing dashboards that integrate various ad channels and lead data. While its focus leans heavily toward digital attribution and marketing performance, it offers analytical tools that can be used for tracking market interactions.
The agency is centered on providing a single live view of marketing efforts, helping clients understand which channels drive revenue and conversions. Its capabilities are primarily focused on digital advertising and search performance.
Scorecard: 54.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 54.0 |
Core services
- Digital Attribution: Tracking leads and revenue across marketing channels.
- Performance Dashboarding: Live view of ad spend, attribution, and call recording.
- Ad Analytics: Measuring creative performance and multi-channel ad metrics.
Strengths
- Digital Integration: Centralizes data from Google and Meta in one live dashboard.
- Revenue Focus: Ties marketing efforts directly to revenue and profit metrics.
- Call Attribution: Records and transcribes phone enquiries to measure their conversion impact.
Innovation and technology
- Live Monitoring: Provides proactive alerts for campaign performance and marketing pace.
- Geospatial Analysis: Maps leads and revenue by postcode to optimize ad spend.
Impact on businesses
- Efficiency Gains: Helps brands stop wasting budget on underperforming channels.
- Strategic Clarity: Provides plain-English insights into what changed in marketing performance and why.
Why it may fit your brief
This provider is excellent for digital marketing optimization. If the objective is deep medical or patient-journey research, other specialized healthcare agencies will offer more relevant methodologies.
How HCP and patient verification actually works in Brazil
Verify respondent credentials through independent license checks and continuous panelist re-validation processes.
Medical License Verification
Providers must verify the professional status of all physicians and healthcare workers against official national registries in Brazil. Demand documented proof of this process for any study involving specialized medical audiences to make sure you are not gathering data from unqualified respondents. Agencies failing to show their verification workflow risk delivering insights based on fraudulent profiles.
Identity Fingerprinting
For online studies, ask for evidence of device, IP, and identity fingerprinting. This helps detect duplicate accounts and professional survey-takers who may misrepresent their credentials. High-quality providers use these technical barriers to protect the validity of the sample.
Rolling Re-validation
The best healthcare panels undergo continuous re-validation of member profiles, especially for key opinion leaders and subspecialists. Ask how often panel members are asked to verify their current practice status. This makes sure that the data is collected from active, relevant professionals rather than stale, outdated records.
Adverse Event Reporting
Make sure the agency has a documented adverse event reporting mechanism that aligns with international guidelines. If a respondent mentions a product complaint during an interview, the agency must have a protocol to report this to you immediately. This is a non-negotiable compliance requirement for pharmaceutical research.
How to choose the right provider in Brazil
Use a clear set of criteria to evaluate the operational and strategic fit of a research partner.
- Assess Local Infrastructure: Confirm the agency has local field operations in Brazil. This makes sure they can manage the unique cultural and linguistic nuances of the domestic medical community.
- Verify Panel Ownership: Prioritize firms that own their proprietary panels. This provides better control over data quality and verification than agencies that simply rent access from third-party networks.
- Review Compliance Protocols: Check for ISO certifications and specific procedures for handling health data. Make sure the provider understands the local data protection laws alongside international standards.
- Check Feasibility Reporting: Ask to see a sample feasibility report. A transparent partner will provide realistic incidence rates and timelines based on their actual panel data.
- Evaluate Analytical Depth: Ask for a redacted case study to review the agency's reporting style. Make sure they provide strategic synthesis rather than just presenting raw data points.
Questions to ask before you commission
- What is your exact process for verifying the medical credentials of your Brazilian panel members?
- Can you provide a detailed description of your adverse event reporting workflow for this project?
- How do you handle low-incidence recruitment for specialists in the Brazilian market?
- What specific fraud detection measures are currently active on your survey platform?
- How does your team make sure that the patient perspectives collected account for the differences between SUS and private health coverage?
- Can you share an example of how you have translated raw research data into a successful commercial strategy?
Common pitfalls to avoid
- Over-reliance on Global Panels: Assuming a global panel will have sufficient depth in Brazil without checking local validation records often leads to poor feasibility.
- Ignoring Local System Dynamics: Failing to account for the split between public and private healthcare leads to skewed insights that do not represent the true market.
- Neglecting Compliance Documentation: Skipping the verification of adverse event reporting procedures creates significant risk for pharmaceutical sponsors.
- Focusing Only on Price: Choosing a partner based on the lowest cost per complete often results in low-quality data that requires expensive re-work.
What a feasibility check should include
A rigorous feasibility check must account for specific medical specialty populations and local recruitment challenges.
Specialty-Specific Incidence
Request a breakdown of the target audience by medical subspecialty. Do not accept aggregate physician counts, as these often hide a lack of depth in specific therapeutic areas.
Geographic Distribution
Make sure the feasibility assessment includes a breakdown by region if your study requires representation across different parts of Brazil.
Patient Access Criteria
Validate how the provider recruits patients, particularly if they need to be treated in specific care settings like private hospitals.
Recruitment Timeline
Ask for a realistic, step-by-step recruitment timeline that includes the time needed for verification and screening of potential participants.
Conclusion
Choosing the right partner from the available pharmaceutical research companies in Brazil depends on your specific study requirements. For high-stakes, multi-stakeholder research that demands strict compliance and deep access to niche medical audiences, Global Vox Populi stands out as a dedicated specialist with verified proprietary panels. If your brief requires large-scale, automated market analytics or real-world evidence, global firms like IQVIA and Ipsos offer significant data scale and strategic consulting capabilities.
For agile, high-touch qualitative projects that require deep local cultural understanding, agencies like ABMR and AQR Fieldwork provide the necessary field presence in São Paulo. Always use the scorecard provided to weigh these providers against your project’s unique needs, prioritizing data integrity, compliance, and specific audience reach to protect the insights you gather effectively support your commercial objectives in 2026.
Planning research in Brazil? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which market research companies in Brazil specialize in healthcare?
Several firms specialize in this area, including Global Vox Populi, Psyma, and ABMR. These agencies focus on healthcare audiences and understand the complex regulatory requirements of the Brazilian market. Larger global firms like IQVIA, Ipsos, and Kantar also maintain dedicated healthcare business units in Brazil, combining broad research scale with specific medical sector expertise.
How do I find reliable pharmaceutical market research agencies in Brazil?
Look for providers that hold ISO 20252 or ISO 9001 certifications and can demonstrate a clear process for medical credential verification. Reliable agencies will provide transparent feasibility reports, have established adverse event reporting protocols, and be able to show deep access to specific physician and patient panels within the domestic market.
Are there global pharmaceutical research firms with offices in Brazil?
Yes, major global firms such as IQVIA, Ipsos, Kantar, and ZS Associates maintain physical offices and specialized teams in Brazil. These global organizations combine international research standards with local teams that possess the necessary knowledge of the Brazilian healthcare system, regulatory environment, and market dynamics.
What is the difference between a CRO and a pharmaceutical market research agency?
A Clinical Research Organization (CRO) primarily manages clinical trials for drug approval, focusing on safety, efficacy, and regulatory compliance for new treatments. A pharmaceutical market research agency focuses on commercial questions, such as brand positioning, market access, patient journey mapping, and physician sentiment, to support marketing and business strategy.
How does the Brazilian healthcare system (SUS vs private) affect market research?
The dual nature of the Brazilian system significantly impacts patient behavior and prescriber dynamics. Market research must account for the different access, treatment, and medication coverage patterns between the public SUS and the private insurance sector. Failing to segment these audiences leads to insights that are not representative of the broader market.
Who are the top qualitative research providers in São Paulo for pharma?
For qualitative studies, agencies like ABMR and AQR Fieldwork offer strong local capabilities in São Paulo. These firms specialize in high-touch methodologies like in-depth interviews, ethnography, and focus groups, providing the nuance required to understand the local physician and patient experience through a culturally informed lens.
Can international pharmaceutical companies conduct market research in Brazil?
Yes, international companies frequently conduct research in Brazil. They typically partner with local agencies or global research firms with a domestic presence to work through the local language, regulatory requirements, and the specific nuances of the Brazilian healthcare market, making sure that all research remains compliant with local and international standards.
What is the role of adverse event reporting in pharmaceutical research?
Adverse event reporting is a mandatory safety protocol in pharmaceutical research. If a respondent reports a potential side effect or product complaint during an interview or survey, the agency must have a structured process to report this information to the pharmaceutical sponsor. This makes sure that safety data is captured in accordance with healthcare regulations.